ATC Group: A07AA11 Rifaximin

Anatomical Therapeutic Chemical Classification System

Hierarchical position in ATC classification

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Intestinal antiinfectives
4
Antibiotics
5
A07AA11
Rifaximin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
0.6 g

Active ingredients

Active Ingredient
Description

Rifaximin is an antibacterial agent of the rifamycin class that inhibits bacterial RNA synthesis. Rifaximin has a broad antimicrobial spectrum against most of the Gram-positive and -negative, aerobic and anaerobic bacteria responsible for intestinal infections.

Medicines in this ATC group

Drug
Countries

Estonia

Tunisia

Ecuador

Ecuador

Ecuador Estonia Tunisia

Austria Hong Kong

Estonia

Ecuador

Finland Ireland United Kingdom

France Spain

Poland Spain

Australia Brazil Hong Kong Netherlands New Zealand ...

United Kingdom

Canada

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL/PLR)
US